Fundz

Electrasteel reported raising $180 Million in an initial SEC Form D filing, from an offering of $257 Million

PUBLIC · ETRAJan 02, 2025$180.4M of $256.7M raised

Amount Raised

$180 Million

$180 Million sold, per SEC Form D (first sale Dec 18, 2024)

Round Type

Venture

South San FranciscoManufacturingBiotechnologySustainabilityHealth CareScience And EngineeringMining

Investors

RA Capital ManagementBlue Owl CapitalCormorant Asset ManagementNew Leaf Venture PartnersRedmile GroupOrbimedMubadala CapitalHBM Healthcare InvestmentsSanofiEQT Life SciencesNextech

Quick answer

Electra Therapeutics raised $180 Million in a funding round, dated December 18, 2024. Investors: RA Capital Management, Blue Owl Capital, Cormorant Asset Management, New Leaf Venture Partners, Redmile Group, Orbimed, Mubadala Capital and HBM Healthcare Investments. Electra Therapeutics is based in South San Francisco, California, United States.

How much did Electra Therapeutics raise?
Electra Therapeutics raised $180 Million in a funding round on December 18, 2024.
Who invested in Electra Therapeutics?
RA Capital Management, Blue Owl Capital, Cormorant Asset Management, New Leaf Venture Partners, Redmile Group, Orbimed, Mubadala Capital and HBM Healthcare Investments are named as investors in this round.
What does Electra Therapeutics do?
Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.
Where is Electra Therapeutics based and how big is it?
Electra Therapeutics is based in South San Francisco, California, United States. Fundz records about 36 employees.
Who are the decision-makers at Electra Therapeutics?
Fundz holds 3 contacts at Electra Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Sustainability and Science And Engineering around the same time

Companies in the same sectors as Electra Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Phlow raised $31M on January 31, 2025.
  • Allurion Technologies raised $7.4M on January 27, 2025.
  • MED-X raised $428K on January 23, 2025.
  • Convergence Medical raised $5M (Series A) on January 16, 2025.
  • Cornerstone Robotics raised $70M (Series C) on January 13, 2025.
  • NewcelX raised $500K (Seed) on January 7, 2025.

Who to call at Electra Therapeutics, and when

A new round usually means Electra Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Electra Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Electra Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Electra Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Electra Therapeutics

Location

230 East Grand Avenue, Suite S-100

South San Francisco, California, United States

About

Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Electra Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Electra Therapeutics's next move

See what Strategic adds

Electra Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.